Skip to content
Back to announcement

Surat Pernyataan Direksi LK Q1 Maret 2024 IKPM.pdf

Financial statement Text extracted IKPM

Source file signed link, expires in 15 minutes

This browser can't display the PDF inline. Open it in a new tab.

Extracted text 1

Page 1 OCR 0.891
Mi PT. IKAPHARMINDO PUTRAMAS Tbk

Pharmaceutical Laboratories

Jl. Pulogadung Raya No. 29, Kawasan Industri Pulogadung, Jakarta Timur 13920 - Indonesia
Phone : #62 21 460 0086/461 4766 (Hunting), Fax : 62 21 460 8865
Email : secretary@ikapharmindo.com, website : www.ikapharmindo.com

SURAT PERNYATAAN DIREKSI BOARD OF DIRECTOR'S STATEMENT
TENTANG TANGGUNG JAWAB REGARDING TO THE RESPONSIBILITY
ATAS LAPORAN KEUANGAN FOR THE FINANCIAL STATEMENTS
31 MARET 2024 (Tidak Diaudit) AS OF MARCH 31, 2024(UnAudited)
DAN UNTUK TAHUN YANG BERAKHIR PADA AND FOR THE YEAR
TANGGAL TERSEBUT THEN ENDED
PT IKAPHARMINDO PUTRAMAS TBK PT IKAPHARMINDO PUTRAMAS TBK

Kami yang bertanda tangan di bawah ini We, the undersigned:

Nama Kartono Name

Alamat kantor Jl. Raya Pulo Gadung No. 29 KIP Jakarta Timur Office address

Alamat domi: KR Anyar Raya 53-54 Blok A No. 25 Jakarta Pusat Residential address

No. Telepon 0214600086 Telephone

Jabatan Direktur Utama / President Director Title

Nama Ayi Saepudin Name

Alamat kantor Jl Raya Pulo Gadung No. 29 KIP Jakarta Timur Office address

Alamat domisili Jl. Sinom III No. 8 Turangga Lengkong Bandung Residential address

No. Telepon 0214600086 Telephone

Jabatan Direktur / Director Title

Mamat bahwa: Derlare that:

Kami bertanggung jawab atas penyusunan dan penyajian laporan We are responsible for the preparation and presentation of the

keuangan PT Ikapharmindo Putramas Tbk: Jinancial statemeris of PT Ikapharmindo Putramas Tbk:

2. Laporan keuangan PT Ikapharmindo Putramas Tbk telah disusun 2. Financial statements of PT Ikapharmindo Putramas Tbk have been
dan disajikan sesuai dengan Standar Akuntansi Keuangan di 'prepared and presented in accordance with Indonesian Financial
Indonesia, Accounting Standards:

3. .& Semua informasi — dalam — laporan — keuangan 3. a. All information in the financial statements of PT Ikapharmindo
PTIkapharmindo Putramas Tbk telah dimuat secara Putramas Tbk have been disclosed in a complete and truthful
lengkap dan benar manner:

b. Laporan keuangan PT Ikapharmindo Putramas Tbk tidak b. Financial statements Of PT Ikapharmindo Putramas Tbk do not
mengandung informasi atau fakta material yang tidak contain any incorrect material information or facts, nor do
benar, dan tidak menghilangkan informasi 'atau fakta they omit any material information or facts:
material:

4. Kami bertanggung jawab atas sistem pengendalian internal 4 We are responsible for PT Ikapharmindo Putramas Tbk internal
dalam PT Ikapharmindo Putramas Tbk. control systems.

Demikian pernyataan ini dibuat dengan sebenarnya. This statement letter is made truthfully.

Jakarta, 29 April 2024 / April 29, 2024

€ Ui

PT.IKAPHARMINDO P

PHARMACEUTICAL

1)

Kartono Ayi Saepudin
Direktur Utama / President Director Direktur / Director

File

File Open PDF
Source IDX
Size0.53 MB
Published17 May 2024
Pages1
Characters2,781
Text sourceOCR
OCR confidence0.891

Names mentioned 3 people and organisations named in the text · linked when the evidence is strong

linked org IKAPHARMINDO PUTRAMAS Tbk p.1 ×32
unresolved org Ikapharmindo PTIkapharmindo Putramas Tbk p.1 ×2
unresolved org Putramas Tbk p.1

Extraction attempts how the parser did, and what it refused

Nothing structured was extracted from this document — the attempts below say why.

No extraction attempted yet.

Other files in this announcement 6

inlineXBRL.zip done
FinancialStatement-2024-I-IKPM.xlsx done
↑↓ select ↵ open ⇧↵ see every result